Three Ignition Grants fueling medical innovation

Supported by the EPFL Ignition Grant, three innovative projects, PolyDefine, Juturna Bio, and SwissIonics, are tackling some of the most pressing challenges in modern medicine. PolyDefine is developing safer, precision-engineered delivery systems for RNA therapeutics, while SwissIonics is creating advanced analytical tools to better understand and control RNA molecules. Complementing these efforts, Juturna Bio is pioneering a gene therapy approach aimed at restoring memory in Alzheimer’s patients. Together, these projects showcase cutting-edge advances across biotechnology and neuroscience, with the potential to transform the treatment of complex diseases.

Raccontata daactu.epfl.ch